Streetbeat News

Products Services

CDXS

Codexis Inc (NASDAQ:CDXS) is discontinuing certain development programs, primarily in Biotherapeutics, and reducing its workforce by 25% to focus on its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis platform and Pharmaceutical Manufacturing business. The company had $92.1 million in cash as of June 30, 2023, and expects this to fund operations until mid-2026. Codexis is also discontinuing its 50/50 development support of CDX-7108 and is negotiating with Nestlé Health Science S.A. to advance the program.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 4:24 pm

RUM

SPY

VGK

The article discusses a video on Rumble featuring Ron DeSantis and Russell Brand discussing various topics including Trump, Fauci, and the war in Ukraine. The video is titled 'Ron DeSantis & Russell Brand: Taking On Trump, Fauci And The War In Ukraine - Stay Free #173'.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 4:12 pm

AAPL

Ben F., a writer for paperstacker.org, has shared some unique side hustles that can supplement income significantly. He mentioned that playing games like solitaire and speed bingo can earn up to $4,000 a week. These games are available on Solitaire Cash and Bingo Cash apps, respectively, in Apple Inc's iOS app store. He also suggested earning cash by testing games and apps through platforms like TesterUp. Additionally, he mentioned that Nielsen pays individuals to share their screen time for research studies.

Portfolio Pulse from Adam Eckert

July 21, 2023 | 4:06 pm

AAPL

RBLX

Roblox announced that it is releasing native support for Roblox and Roblox Studio on devices powered by Apple Silicon.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 4:05 pm

ADCT

ADC Therapeutics SA has announced the discontinuation of the Phase 2 LOTIS-9 trial evaluating Zynlonta and rituximab in unfit or frail patients with previously untreated diffuse large B-cell lymphoma (DLBCL). The decision follows a voluntary pause in enrollment due to potentially excessive respiratory-related events, including seven fatal events. The FDA has placed a partial clinical hold on the trial for new patient enrollment. ADC Therapeutics' shares are down 6.00%.

Portfolio Pulse from Vandana Singh

July 21, 2023 | 3:56 pm

ADDYY

MGOL

Lionel Messi's move to Inter Miami has caused a surge in demand for merchandise, particularly jerseys, causing a supply chain headache for manufacturers and retailers. Adidas, the German sportswear supplier, is struggling to meet the demand, despite speeding up its manufacturing process. Sports Endeavors, which owns soccer.com, sold out six months of Inter Miami stock in 24 hours. The company expects the increased sales to more than offset any losses from Messi's former team, Paris Saint-Germain.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 3:49 pm

UAL

United Airlines Holdings Inc (NASDAQ:UAL) has invested in Electric Power Systems (EPS), a company that produces battery technology for aerospace applications. The investment is part of United's strategy to use EPS modules in its current ground operations and potentially in an all-electric flight academy in the future. This is United's second investment in electric battery technology, following an investment in sodium-ion battery-maker Natron. EPS aims to provide a complete battery ecosystem for aviation, including aircraft packs and ground charging stations.

Portfolio Pulse from Shivani Kumaresan

July 21, 2023 | 3:25 pm

MAT

Mattel CEO Ynon Kreiz discussed the opening weekend for 'Barbie' on CNBC. No specific details about the performance or future plans were provided.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 3:18 pm

JAZZ

A bipartisan group of U.S. lawmakers reintroduced a measure to secure the FDA’s regulation of hemp-derived CBD products. The move comes seven months after the FDA announced it will not regulate CBD products as food and dietary supplements. The goal of the announced subcommittee hearing is to examine the FDA’s failure to regulate hemp-derived and cannabidiol (CBD) products under existing authorities for years. The FDA approved Jazz Pharmaceuticals' Epidiolex, a CBD-based drug for treating severe forms of epilepsy.

Portfolio Pulse from Nina Zdinjak

July 21, 2023 | 2:35 pm

TSLA

Tesla Inc's Cybertruck has been spotted with a new darker camouflage wrap, sparking rumors among industry observers. This follows the initial discovery of a Cybertruck in camouflage wrap last month. Automakers often use camouflage on their vehicles as they approach the production stage. Tesla recently announced it had built the first Cybertruck, but clarified in its second-quarter earnings that it was currently only producing release candidates.

Portfolio Pulse from Benzinga EV Insights

July 21, 2023 | 2:22 pm